Kiromic BioPharma Inc. (KRBP)

OTC: KRBP · Real-Time Price · USD

0.20

0.00 (0.05%)

At close: Mar 24, 2025, 3:59 PM

Kiromic BioPharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	1.14M	3.2M	645.2K	25.35M	10.15M	1.93M	384.3K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	21K	21.4K	24.4K	31.1K	24.4K	24.4K	17.8K
Receivables	n/a	n/a	n/a	16.2K	n/a	n/a	24.3K
Inventory	n/a	n/a	n/a	n/a	n/a	22.2K	16.3K
Other Current Assets	2.16M	1.23M	1.04M	1.7M	588.8K	n/a	n/a
Total Current Assets	3.3M	4.43M	1.69M	27.07M	10.74M	2.04M	560.2K
Property-Plant & Equipment	5.22M	7.72M	10.25M	3.63M	2.07M	587.9K	298K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	5.24M	7.74M	10.28M	3.66M	2.09M	612.3K	315.8K
Total Assets	8.54M	12.17M	11.97M	30.73M	12.83M	2.65M	876K
Account Payables	2.68M	2.14M	7.31M	2.21M	665.2K	452.4K	219.1K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	685K	14M	4.37M	454.5K	468K	n/a	n/a
Other Current Liabilities	16.86M	2.75M	355K	467.1K	143.4K	n/a	246.6K
Total Current Liabilities	20.9M	20.38M	13.28M	3.41M	1.47M	673.7K	610.7K
Long-Term Debt	13.47M	n/a	2.91M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	-228K	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	13.47M	911.5K	4.46M	n/a	n/a	n/a	n/a
Total Liabilities	21.13M	21.29M	17.74M	3.41M	1.47M	673.7K	610.7K
Total Debt	14.57M	15.54M	9.41M	454.5K	468K	n/a	n/a
Common Stock	2K	1.26K	648.00	9.3K	1.2K	n/a	n/a
Retained Earnings	-149.79M	-122.9M	-101.95M	-67.22M	-41.63M	-22.43M	-18.7M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-274.2K
Shareholders Equity	-12.59M	-9.12M	-5.77M	27.32M	11.36M	1.98M	265.3K
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a